151 related articles for article (PubMed ID: 8106075)
1. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts.
Cavari S; Ruggiero M; Vannucchi S
Cell Biol Int; 1993 Aug; 17(8):781-6. PubMed ID: 8106075
[TBL] [Abstract][Full Text] [Related]
2. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
Fry DG; Milam LD; Maher VM; McCormick JJ
J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell.
Kim HR; Upadhyay S; Korsmeyer S; Deuel TF
J Biol Chem; 1994 Dec; 269(48):30604-8. PubMed ID: 7982979
[TBL] [Abstract][Full Text] [Related]
6. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
Vennström B; Bravo R
Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775
[TBL] [Abstract][Full Text] [Related]
7. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
8. NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: effect on inositol lipid turnover.
Ruggiero M; Srivastava SK; Fleming TP; Ron D; Eva A
Oncogene; 1989 Jun; 4(6):767-71. PubMed ID: 2543945
[TBL] [Abstract][Full Text] [Related]
9. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
10. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells.
Melchiori A; Carlone S; Allavena G; Aresu O; Parodi S; Aaronson SA; Albini A
Anticancer Res; 1990; 10(1):37-44. PubMed ID: 2334141
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB
Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747
[TBL] [Abstract][Full Text] [Related]
12. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
[TBL] [Abstract][Full Text] [Related]
13. Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods.
Carpenter PM; Mercola M; Mercola D
Antisense Res Dev; 1991; 1(3):289-95. PubMed ID: 1821651
[TBL] [Abstract][Full Text] [Related]
14. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
15. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
18. Negative growth control by a novel low M(r) phosphotyrosine protein phosphatase in normal and transformed cells.
Ruggiero M; Pazzagli C; Rigacci S; Magnelli L; Raugei G; Berti A; Chiarugi VP; Pierce JH; Camici G; Ramponi G
FEBS Lett; 1993 Jul; 326(1-3):294-8. PubMed ID: 8100784
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
20. Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.
Fleming TP; Matsui T; Molloy CJ; Robbins KC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8063-7. PubMed ID: 2813378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
